RUBY logo

Rubius Therapeutics (RUBY) Selling, General & Administrative Expenses

Annual SGA

$30.84 M
-$22.19 M-41.85%

December 31, 2022

Summary

Performance

1-Year Change

-41.85%

3-Year Change

-46.08%

5-Year Change

+39.92%

15-Year Change

+39.92%

RUBY SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$57.18 M
RUBY annual SGA is currently -46.08% below its historical high of $57.18 million

3-Year Low

$30.84 M
RUBY annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
RUBY previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
RUBY next annual earnings announcement has not yet been scheduled

OtherRUBYexpensesmetrics:

Annual Total Expenses

$127.25 M
RUBY annual total expenses is $127.25 million

Annual Operating Expenses

$127.25 M
RUBY annual total operating expenses is $127.25 million

Annual Cost Of Goods Sold

-
RUBY annual cost of goods sold value is unknown

Annual Interest Expense

$3.86 M
RUBY annual interest expense is $3.86 million

Quarterly SGA

$1.06 M
-$6.24 M-85.44%

December 31, 2022

Summary

Performance

3-Month Change

-85.44%

1-Year Change

-92.35%

3-Year Change

-92.88%

5-Year Change

-90.23%

RUBY Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$14.95 M
RUBY quarterly SGA is currently -92.89% below its historical high of $14.95 million

3-Year Low

$1.06 M
RUBY quarterly SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
RUBY previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
RUBY next earnings announcement has not yet been scheduled

OtherRUBYexpensesmetrics:

Quarterly Total Expenses

$1.95 M
RUBY quarterly total expenses is $1.95 million

Quarterly Operating Expenses

$1.95 M
RUBY quarterly total operating expenses is $1.95 million

Quarterly Cost Of Goods Sold

-
RUBY quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-$1.13 M
RUBY quarterly interest expense is -$1.13 million

TTM SGA

-$3.20 B
-$179.67 M-5.96%

December 31, 2022

Summary

Performance

3-Month Change

-7418.44%

1-Year Change

-6127.51%

3-Year Change

-5689.75%

5-Year Change

-5689.75%

RUBY TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$60.98 M

3-Year Low

-$3.20 B
RUBY TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
RUBY previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
RUBY next earnings announcement has not yet been scheduled

OtherRUBYexpensesmetrics:

Annual Total Expenses

$127.25 M
RUBY annual total expenses is $127.25 million

Annual Operating Expenses

$127.25 M
RUBY annual total operating expenses is $127.25 million

TTM Cost Of Goods Sold

-
RUBY TTM cost of goods sold value is unknown

TTM Interest Expense

$3.86 M
RUBY TTM interest expense is $3.86 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$30.84 M
RUBY annual SGA is $30.84 million

Annual Operating Expenses

$127.25 M
RUBY annual total operating expenses is $127.25 million

Annual Cost Of Goods Sold

-
RUBY annual cost of goods sold value is unknown

RUBY Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-41.9%-92.3%-6127.5%
3 y3 years-46.1%-92.9%-5689.8%
5 y5 years+39.9%-90.2%-5689.8%

RUBY Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-41.9%at low-92.4%at low+33.5%at low
5 y5-year-46.1%at low-92.9%at low+224.8%at low
alltimeall time-46.1%-92.1%-92.9%at low+5141.7%at low

Rubius Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2022
$30.84 M(-41.9%)
$1.06 M(-85.4%)
$30.84 M(-29.4%)
Sep 2022
-
$7.30 M(-26.3%)
$43.67 M(-9.8%)
Jun 2022
-
$9.91 M(-21.1%)
$48.41 M(-7.5%)
Mar 2022
-
$12.56 M(-9.6%)
$52.35 M(-1.3%)
Dec 2021
$53.03 M(+5.3%)
$13.90 M(+15.5%)
$53.03 M(-0.4%)
Sep 2021
-
$12.04 M(-13.1%)
$53.23 M(+0.1%)
Jun 2021
-
$13.85 M(+4.6%)
$53.17 M(+4.4%)
Mar 2021
-
$13.24 M(-6.1%)
$50.92 M(+1.1%)
Dec 2020
$50.34 M(-12.0%)
$14.10 M(+17.7%)
$50.34 M(-1.6%)
Sep 2020
-
$11.98 M(+3.2%)
$51.17 M(-5.5%)
Jun 2020
-
$11.60 M(-8.4%)
$54.15 M(-3.8%)
Mar 2020
-
$12.66 M(-15.2%)
$56.31 M(-1.5%)
DateAnnualQuarterlyTTM
Dec 2019
$57.18 M(+43.3%)
$14.93 M(-0.2%)
$57.18 M(+4.3%)
Sep 2019
-
$14.95 M(+8.6%)
$54.84 M(+3.3%)
Jun 2019
-
$13.77 M(+1.7%)
$53.08 M(+9.8%)
Mar 2019
-
$13.54 M(+7.6%)
$48.33 M(+21.2%)
Dec 2018
$39.89 M(+81.0%)
$12.58 M(-4.6%)
$39.89 M(+4.5%)
Sep 2018
-
$13.19 M(+46.2%)
$38.19 M(+23.8%)
Jun 2018
-
$9.02 M(+77.0%)
$30.84 M(+18.5%)
Mar 2018
-
$5.10 M(-53.1%)
$26.03 M(+18.1%)
Dec 2017
$22.04 M(+799.9%)
$10.88 M(+85.9%)
$22.04 M(+97.4%)
Sep 2017
-
$5.85 M(+38.9%)
$11.16 M(+110.1%)
Jun 2017
-
$4.21 M(+282.2%)
$5.31 M(+382.2%)
Mar 2017
-
$1.10 M
$1.10 M
Dec 2016
$2.45 M
-
-

FAQ

  • What is Rubius Therapeutics annual SGA?
  • What is the all time high annual SGA for Rubius Therapeutics?
  • What is Rubius Therapeutics annual SGA year-on-year change?
  • What is Rubius Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Rubius Therapeutics?
  • What is Rubius Therapeutics quarterly SGA year-on-year change?
  • What is Rubius Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Rubius Therapeutics?
  • What is Rubius Therapeutics TTM SGA year-on-year change?

What is Rubius Therapeutics annual SGA?

The current annual SGA of RUBY is $30.84 M

What is the all time high annual SGA for Rubius Therapeutics?

Rubius Therapeutics all-time high annual SGA is $57.18 M

What is Rubius Therapeutics annual SGA year-on-year change?

Over the past year, RUBY annual SGA has changed by -$22.19 M (-41.85%)

What is Rubius Therapeutics quarterly SGA?

The current quarterly SGA of RUBY is $1.06 M

What is the all time high quarterly SGA for Rubius Therapeutics?

Rubius Therapeutics all-time high quarterly SGA is $14.95 M

What is Rubius Therapeutics quarterly SGA year-on-year change?

Over the past year, RUBY quarterly SGA has changed by -$12.84 M (-92.35%)

What is Rubius Therapeutics TTM SGA?

The current TTM SGA of RUBY is -$3.20 B

What is the all time high TTM SGA for Rubius Therapeutics?

Rubius Therapeutics all-time high TTM SGA is -$60.98 M

What is Rubius Therapeutics TTM SGA year-on-year change?

Over the past year, RUBY TTM SGA has changed by -$3.25 B (-6127.51%)